SARS - COV2感染在急性胰腺炎演变中的作用(综述)

IF 2.3 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Biomedical reports Pub Date : 2023-07-01 DOI:10.3892/br.2023.1632
Vlad Pădureanu, Daniel Cosmin Caragea, Mirela Marinela Florescu, Ionela Mihaela Vladu, Patricia Mihaela Rădulescu, Dan Nicolae Florescu, Dumitru Rădulescu, Rodica Pădureanu, Ion Cristian Efrem
{"title":"SARS - COV2感染在急性胰腺炎演变中的作用(综述)","authors":"Vlad Pădureanu,&nbsp;Daniel Cosmin Caragea,&nbsp;Mirela Marinela Florescu,&nbsp;Ionela Mihaela Vladu,&nbsp;Patricia Mihaela Rădulescu,&nbsp;Dan Nicolae Florescu,&nbsp;Dumitru Rădulescu,&nbsp;Rodica Pădureanu,&nbsp;Ion Cristian Efrem","doi":"10.3892/br.2023.1632","DOIUrl":null,"url":null,"abstract":"<p><p>Acute pancreatitis is characterized as an inflammatory illness that is life-threatening and causes necrosis as well as simple edema when pancreatic enzymes are activated intraglandularly. It is not known whether severe acute respiratory syndrome coronavirus 2 causes acute pancreatitis. Patients with acute pancreatitis who test positive for coronavirus disease 2019 (COVID-19) frequently have biliary or alcoholic causes. It is unclear how common acute pancreatitis is in patients with COVID-19. By contrast with patients without COVID-19, however, COVID-19-positive patients with acute pancreatitis have a higher mortality as well as a higher risk of necrosis and admission to an intensive care unit. The most common cause of mortality in COVID-19-positive individuals with concurrent severe pancreatitis is acute respiratory distress syndrome. The present study discussed research on the link between COVID-19 infection and acute pancreatitis.</p>","PeriodicalId":8863,"journal":{"name":"Biomedical reports","volume":"19 1","pages":"49"},"PeriodicalIF":2.3000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/38/e9/br-19-01-01632.PMC10293881.pdf","citationCount":"1","resultStr":"{\"title\":\"Role of the SARS‑COV2 infection in the evolution of acute pancreatitis (Review).\",\"authors\":\"Vlad Pădureanu,&nbsp;Daniel Cosmin Caragea,&nbsp;Mirela Marinela Florescu,&nbsp;Ionela Mihaela Vladu,&nbsp;Patricia Mihaela Rădulescu,&nbsp;Dan Nicolae Florescu,&nbsp;Dumitru Rădulescu,&nbsp;Rodica Pădureanu,&nbsp;Ion Cristian Efrem\",\"doi\":\"10.3892/br.2023.1632\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Acute pancreatitis is characterized as an inflammatory illness that is life-threatening and causes necrosis as well as simple edema when pancreatic enzymes are activated intraglandularly. It is not known whether severe acute respiratory syndrome coronavirus 2 causes acute pancreatitis. Patients with acute pancreatitis who test positive for coronavirus disease 2019 (COVID-19) frequently have biliary or alcoholic causes. It is unclear how common acute pancreatitis is in patients with COVID-19. By contrast with patients without COVID-19, however, COVID-19-positive patients with acute pancreatitis have a higher mortality as well as a higher risk of necrosis and admission to an intensive care unit. The most common cause of mortality in COVID-19-positive individuals with concurrent severe pancreatitis is acute respiratory distress syndrome. The present study discussed research on the link between COVID-19 infection and acute pancreatitis.</p>\",\"PeriodicalId\":8863,\"journal\":{\"name\":\"Biomedical reports\",\"volume\":\"19 1\",\"pages\":\"49\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/38/e9/br-19-01-01632.PMC10293881.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedical reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3892/br.2023.1632\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/br.2023.1632","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 1

摘要

急性胰腺炎的特征是一种危及生命的炎症性疾病,当胰腺酶在肠道内被激活时,会导致坏死和单纯水肿。目前尚不清楚严重急性呼吸综合征冠状病毒2是否会引起急性胰腺炎。2019冠状病毒病(COVID-19)检测呈阳性的急性胰腺炎患者通常有胆道或酒精原因。目前尚不清楚COVID-19患者的急性胰腺炎有多常见。然而,与未感染COVID-19的患者相比,COVID-19阳性急性胰腺炎患者的死亡率更高,坏死和入住重症监护病房的风险也更高。covid -19阳性患者并发严重胰腺炎的最常见死亡原因是急性呼吸窘迫综合征。本研究讨论了COVID-19感染与急性胰腺炎之间关系的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Role of the SARS‑COV2 infection in the evolution of acute pancreatitis (Review).

Acute pancreatitis is characterized as an inflammatory illness that is life-threatening and causes necrosis as well as simple edema when pancreatic enzymes are activated intraglandularly. It is not known whether severe acute respiratory syndrome coronavirus 2 causes acute pancreatitis. Patients with acute pancreatitis who test positive for coronavirus disease 2019 (COVID-19) frequently have biliary or alcoholic causes. It is unclear how common acute pancreatitis is in patients with COVID-19. By contrast with patients without COVID-19, however, COVID-19-positive patients with acute pancreatitis have a higher mortality as well as a higher risk of necrosis and admission to an intensive care unit. The most common cause of mortality in COVID-19-positive individuals with concurrent severe pancreatitis is acute respiratory distress syndrome. The present study discussed research on the link between COVID-19 infection and acute pancreatitis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Biomedical reports
Biomedical reports MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
4.10
自引率
0.00%
发文量
86
期刊介绍: Biomedical Reports is a monthly, peer-reviewed journal, dedicated to publishing research across all fields of biology and medicine, including pharmacology, pathology, gene therapy, genetics, microbiology, neurosciences, infectious diseases, molecular cardiology and molecular surgery. The journal provides a home for original research, case reports and review articles.
期刊最新文献
Chemical composition and pharmacological aspects of Malaysian stingless bee propolis: An up‑to‑date systematic review. Network pharmacology analysis and clinical verification of Panax notoginseng saponins in deep venous thrombosis prevention. Biological variation of capillary blood glucose: A systematic review. Design, synthesis, biological and in silico evaluation of 3‑carboxy‑coumarin sulfonamides as potential antiproliferative agents targeting HDAC6. Lack of glycemic control in type two diabetes mellitus patients is associated with reduced serum epidermal growth factor level and increased insulin resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1